Bayer AG
- B01 - Agentes antitrombóticos
- VENTAVIS nebuliser solution 20 µg/2 ml
- XARELTO film-coated tablet 10 mg
- XARELTO film-coated tablet 15 mg
- XARELTO film-coated tablet 2.5 mg
- XARELTO film-coated tablet 20 mg
- XARELTO granules for oral suspension 1 mg/ml
- B02 - Antihemorrágicos
- JIVI powder and solvent for solution for injection 1 000 IU
- JIVI powder and solvent for solution for injection 2 000 IU
- JIVI powder and solvent for solution for injection 250 IU
- JIVI powder and solvent for solution for injection 3 000 IU
- JIVI powder and solvent for solution for injection 500 IU
- KOGENATE powder and solvent for solution for injection 250 IU+2.5 ml
- KOVALTRY powder and solvent for solution for injection 250 IU
- C01 - Terapia cardíaca
- VERQUVO film-coated tablet 10 mg
- VERQUVO film-coated tablet 2.5 mg
- VERQUVO film-coated tablet 5 mg
- C02 - Antihipertensivos
- ADEMPAS film-coated tablet 0.5 mg
- ADEMPAS film-coated tablet 1 mg
- ADEMPAS film-coated tablet 1.5 mg
- ADEMPAS film-coated tablet 2 mg
- ADEMPAS film-coated tablet 2.5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- KINZALKOMB tablet 40 mg+12.5 mg
- KINZALKOMB tablet 80 mg+25 mg
- KINZALMONO tablet 40 mg
- PRITOR tablet 20 mg
- PRITOR tablet 40 mg
- PRITOR tablet 80 mg
- PRITORPLUS tablet 40 mg+12.5 mg
- PRITORPLUS tablet 80 mg+25 mg
- G04 - Urológicos
- LEVITRA film-coated tablet 5 mg
- L01 - Antineoplásicos
- NEXAVAR film-coated tablet 200 mg
- VITRAKVI capsule, hard 100 mg
- VITRAKVI capsule, hard 25 mg
- L02 - Terapia endocrina
- NUBEQA film-coated tablet 300 mg
- L03 - Inmunoestimulantes
- BETAFERON powder and solvent for solution for injection 750 µg+3 ml
- S01 - Oftalmológicos
- EYLEA solution for injection 40 mg/ml
- V10 - Radiofármacos terapéuticos
- XOFIGO solution for injection 1 000 KBq/ml